Forwarded from THE WATERS ABOVE
This media is not supported in your browser
VIEW IN TELEGRAM
Heres a video taken by me of the REAL Jupiter. Stars are not physical,but light in Gods firmament #nikonp1000
Forwarded from THE WATERS ABOVE
This media is not supported in your browser
VIEW IN TELEGRAM
Sirius from a few years ago.
Taken with a Nikon P1000.
Curtasy from Zach from the USA.
Zach has just joined the group and hopefully can send us some truth what is actually up there.
Welcome Zach 🙏
Taken with a Nikon P1000.
Curtasy from Zach from the USA.
Zach has just joined the group and hopefully can send us some truth what is actually up there.
Welcome Zach 🙏
Forwarded from THE WATERS ABOVE
Various planets in the Waters above, Nikon Coolpix P1000.
August 2021.
August 2021.
Forwarded from The Arrivals
Media is too big
VIEW IN TELEGRAM
Forwarded from The Course of Empire (Uncensored)
Sounds similar to something reported on Sept. 10th, 2001.
This media is not supported in your browser
VIEW IN TELEGRAM
🏦 HOW TO ROB DIAMONDS FROM A BANK 💎
🎬 (Snatch)
🎬 (Snatch)
⚡1
jiad352.pdf
573.1 KB
OJID (Oxford Journal of Infectious Diseases) 3 issue catch up (Drop 1 of 4)
Well it's been a while since I posted anything by the OJID, mostly due to other priorities project-wise and so I thought it high time I revisited them?
So in this drop we have papers on Ebola, Marburg and Covid to get through (and before the Terrain mob try screaming 'Blue Murder', how exactly do you expect to argue with these people, if your entire argument is based around, 'But viruses don't exist'?
"Know thine enemy" Sun Tzu 'The Art of War')
1) The Multiple Origins of Ebola Disease Outbreaks
2) Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting
3) RNA Editing as a General Trait of Ebolaviruses
4) Ebola Virus Uses Tunneling Nanotubes as an Alternate Route of Dissemination
5) A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus
Well it's been a while since I posted anything by the OJID, mostly due to other priorities project-wise and so I thought it high time I revisited them?
So in this drop we have papers on Ebola, Marburg and Covid to get through (and before the Terrain mob try screaming 'Blue Murder', how exactly do you expect to argue with these people, if your entire argument is based around, 'But viruses don't exist'?
"Know thine enemy" Sun Tzu 'The Art of War')
1) The Multiple Origins of Ebola Disease Outbreaks
2) Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting
3) RNA Editing as a General Trait of Ebolaviruses
4) Ebola Virus Uses Tunneling Nanotubes as an Alternate Route of Dissemination
5) A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus
jiad208.pdf
548.7 KB
OJID (Oxford Journal of Infectious Diseases) 3 issue catch up (Drop 2 of 4)
1) Preexisting Immunity Does Not Prevent Efficacy
of Vesicular Stomatitis Virus–Based Filovirus Vaccines in Nonhuman Primates
2) Single-Dose Treatment With Vesicular Stomatitis
Virus–Based Ebola Virus Vaccine Expressing Ebola
Virus–Specific Artificial Micro-RNA Does Not Protect Mice From Lethal Disease
3) A Recombinant Vesicular Stomatitis Virus–Based Vaccine Provides Postexposure Protection Against Bundibugyo
Ebolavirus Infection
4) Limited Benefit of Postexposure Prophylaxis With VSV-EBOV in Ebola Virus–Infected Rhesus Macaques
5) Clinical Antiviral Efficacy of Remdesivir in Cov19: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
1) Preexisting Immunity Does Not Prevent Efficacy
of Vesicular Stomatitis Virus–Based Filovirus Vaccines in Nonhuman Primates
2) Single-Dose Treatment With Vesicular Stomatitis
Virus–Based Ebola Virus Vaccine Expressing Ebola
Virus–Specific Artificial Micro-RNA Does Not Protect Mice From Lethal Disease
3) A Recombinant Vesicular Stomatitis Virus–Based Vaccine Provides Postexposure Protection Against Bundibugyo
Ebolavirus Infection
4) Limited Benefit of Postexposure Prophylaxis With VSV-EBOV in Ebola Virus–Infected Rhesus Macaques
5) Clinical Antiviral Efficacy of Remdesivir in Cov19: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)